These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 8100664)

  • 1. Challenges and strategies for AIDS vaccine development.
    Oxford JS; Frezza P; Race E
    Vaccine; 1993; 11(6):612-4. PubMed ID: 8100664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards an HIV-1 vaccine: lessons from studies in macaque models.
    Hulskotte EG; Geretti AM; Osterhaus AD
    Vaccine; 1998; 16(9-10):904-15. PubMed ID: 9682336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current situation in the development of a preventive HIV vaccine.
    Alcamí J; Joseph Munné J; Muñoz-Fernández MA; Esteban M
    Enferm Infecc Microbiol Clin; 2005 Jul; 23 Suppl 2():5-24. PubMed ID: 16373000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV vaccine design: insights from live attenuated SIV vaccines.
    Koff WC; Johnson PR; Watkins DI; Burton DR; Lifson JD; Hasenkrug KJ; McDermott AB; Schultz A; Zamb TJ; Boyle R; Desrosiers RC
    Nat Immunol; 2006 Jan; 7(1):19-23. PubMed ID: 16357854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of an AIDS vaccine using Sendai virus vectors.
    Ishii H; Matano T
    Vaccine; 2015 Nov; 33(45):6061-5. PubMed ID: 26232346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress with HIV vaccines.
    Biberfeld G; Emini EA
    AIDS; 1991; 5 Suppl 2():S129-33. PubMed ID: 1845044
    [No Abstract]   [Full Text] [Related]  

  • 7. Assessing animal models of AIDS.
    Stott J; Almond N
    Nat Med; 1995 Apr; 1(4):295-7. PubMed ID: 7585052
    [No Abstract]   [Full Text] [Related]  

  • 8. Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model.
    Nehete PN; Chitta S; Hossain MM; Hill L; Bernacky BJ; Baze W; Arlinghaus RB; Sastry KJ
    Vaccine; 2001 Dec; 20(5-6):813-25. PubMed ID: 11738745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a vaccine for the prevention of AIDS, a critical appraisal.
    Karzon DT; Bolognesi DP; Koff WC
    Vaccine; 1992; 10(14):1039-52. PubMed ID: 1281948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SIV vaccines, 1991--a year in review.
    Gardner MB; Hu SL
    AIDS; 1991; 5 Suppl 2():S115-27. PubMed ID: 1845043
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunization for long-term protection against AIDS using the macaque model.
    Kumar A; Narayan O
    Virology; 2001 Jun; 285(1):1-5. PubMed ID: 11414799
    [No Abstract]   [Full Text] [Related]  

  • 12. HIV-1 vaccines based on replication-competent Tiantan vaccinia protected Chinese rhesus macaques from simian HIV infection.
    Liu Q; Li Y; Luo Z; Yang G; Liu Y; Liu Y; Sun M; Dai J; Li Q; Qin C; Shao Y
    AIDS; 2015 Mar; 29(6):649-58. PubMed ID: 25849828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AIDS preclinical vaccine development: biennial survey of HIV, SIV, and SHIV challenge studies in vaccinated nonhuman primates.
    Warren JT; Levinson MA
    J Med Primatol; 1999; 28(4-5):249-73. PubMed ID: 10593492
    [No Abstract]   [Full Text] [Related]  

  • 14. AIDS vaccine development in primate models.
    Almond NM; Heeney JL
    AIDS; 1998; 12 Suppl A():S133-40. PubMed ID: 9632994
    [No Abstract]   [Full Text] [Related]  

  • 15. Protection against human immunodeficiency virus type 2 and simian immunodeficiency virus in macaques vaccinated against human immunodeficiency virus type 2.
    Biberfeld G; Thorstensson R; Putkonen P
    AIDS Res Hum Retroviruses; 1996 Mar; 12(5):443-6. PubMed ID: 8882330
    [No Abstract]   [Full Text] [Related]  

  • 16. Whole inactivated SIV vaccine grown on human cells fails to protect against homologous SIV grown on simian cells.
    Putkonen P; Nilsson C; Hild K; Benthin R; Cranage M; Aubertin AM; Biberfeld G
    J Med Primatol; 1993; 22(2-3):100-3. PubMed ID: 8411101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monkey business over AIDS vaccine.
    Weiss R
    BMJ; 1991 Oct; 303(6807):872. PubMed ID: 1933002
    [No Abstract]   [Full Text] [Related]  

  • 18. SIV infection of macaques: a model for AIDS vaccine development.
    Gardner MB
    Dev Biol Stand; 1990; 72():259-66. PubMed ID: 2178124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevance of studying T cell responses in SIV-infected rhesus macaques.
    Valentine LE; Watkins DI
    Trends Microbiol; 2008 Dec; 16(12):605-11. PubMed ID: 18964016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of macaques against simian immunodeficiency virus infection with inactivated vaccines: comparison of adjuvants, doses and challenge viruses. The European Concerted Action on 'Macaque Models for AIDS Research'.
    Vaccine; 1995 Feb; 13(3):295-300. PubMed ID: 7631516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.